Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Parkinson's Disease Article Ethics in movement disorders – what the clinician needs to know Depression Article Ketamine metabolite may hold a key to novel antidepressants Migraine Article Management of medication overuse headache Schizophrenia Article Acceptability of Long-acting Injectables (LAIs) for Schizophrenia Treatment in Taiwan